Ultragenyx Pharmaceutical Inc. (RARE) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 23.43 and resistance at 27.95. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 37.03, so a violation there would materially change the current setup narrative.

📊 Technical Summary

Ultragenyx Pharmaceutical Inc. (RARE) finished the session at 24.69 (+2.11%). Short-term positioning has improved with price above the 50-day average, although the chart still needs to reclaim the 200-day average to fully repair the bigger picture. 20-day momentum is notably strong at +15.27%; price remains inside its roughly 52-week range (18.50–41.44); and ATR14 volatility is running near 4.40% of price. RSI(14) reads 58.9, suggesting buyers still hold the momentum advantage. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram remains negative, suggesting momentum is still on the softer side. The most important nearby levels are support at 23.43 and resistance at 27.95. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Revenue: 159.93M · Net income: -180.41M · EPS (basic): -1.81. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more